DESTINY PHARMA
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products. Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the drug-resistant bacteria that are at the centre of a global healthcare crisis.
DESTINY PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1996-01-01
Address:
Brighton, East Sussex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.destinypharma.com
Total Employee:
11+
Status:
Active
Contact:
+441273704499
Total Funding:
46.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Apache Global Site Tag
Current Employees Featured
Shaun Claydon Chief Financial Officer and Company Secretary @ Destiny Pharma
Chief Financial Officer and Company Secretary
Stephanie Bewick Chief Business Officer @ Destiny Pharma
Chief Business Officer
2021-01-01
William Love Founder and Chief Scientific Officer @ Destiny Pharma
Founder and Chief Scientific Officer
Neil Clark Chief Executive Officer @ Destiny Pharma
Chief Executive Officer
2017-01-01
Founder
Stock Details
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Destiny Pharma
Antimicrobial resistance
Antimicrobial resistance investment in Grant - Destiny Pharma
CMS Medical Venture Investment
CMS Medical Venture Investment investment in Post-IPO Equity - Destiny Pharma
Downing LLP
Downing LLP investment in Post-IPO Equity - Destiny Pharma
China Medical System Holdings Limited
China Medical System Holdings Limited investment in Venture Round - Destiny Pharma
Downing Ventures
Downing Ventures investment in Venture Round - Destiny Pharma
Juno Capital Partners
Juno Capital Partners investment in Venture Round - Destiny Pharma
ACF Investors
ACF Investors investment in Venture Round - Destiny Pharma
Longbow Capital
Longbow Capital investment in Venture Round - Destiny Pharma
Official Site Inspections
http://www.destinypharma.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K
- Host name: cloudhost-69408.uk-south-2.nxcli.net
- IP address: 165.84.219.41
- Location: Byfleet United Kingdom
- Latitude: 51.3388
- Longitude: -0.474
- Timezone: Europe/London
- Postal: KT14
More informations about "Destiny Pharma"
About us - Destiny Pharma
About us Destiny Pharma is a clinical phase biotechnology company dedicated to infection prevention. The company has two late stage clinical programmes and an earlier preclinical …See details»
Destiny Pharma - Crunchbase Company Profile & Funding
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products. Our XF series of compounds have a mechanism of action that is …See details»
Destiny Pharma Limited - In Administration | LinkedIn
Destiny Pharma Limited - In Administration Biotechnology Research Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability.See details»
Destiny Pharma Company Profile | Management and Employees …
Destiny Pharma Profile and History Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening …See details»
Investors - Destiny Pharma
Destiny Pharma Limited - In Administration Sussex Innovation Centre Science Park Square Brighton BN1 9SB UKSee details»
Destiny Pharma plc: Shareholders Board Members Managers and …
Aug 31, 2011 Destiny Pharma plc is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of novel medicines that can prevent life …See details»
Destiny Pharma - VentureRadar
"Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel …See details»
Destiny Pharma - Overview, News & Similar companies - ZoomInfo
Jan 15, 2021 View Destiny Pharma (www.destinypharma.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as …See details»
Destiny Pharma - Craft
Destiny Pharma is a clinical phase biotechnology company that specializes in treatments of infectious disease. It develops drugs for the prevention and treatment of life‑threatening …See details»
Destiny Pharma Limited - JP Jenkins
Mar 4, 1996 Destiny Pharma is a clinical phase biotechnology company dedicated to infection prevention. The company has two late stage clinical programmes and an earlier preclinical …See details»
Destiny Pharma - Products, Competitors, Financials, Employees ...
About Destiny Pharma Destiny Pharma is a clinical stage biotechnology company that develops medicines for infection prevention. The company works on microbiome-based biotherapeutics …See details»
Organization: Destiny Pharma LEI 213800O9WH9Z38EHAC95
Destiny Pharma. Information about the issuer. News and credit ratings. (LEI 213800O9WH9Z38EHAC95). Tables with accounting and financial reporting.See details»
Destiny Pharma 2025 Company Profile: Stock Performance
Information on stock, financials, earnings, subsidiaries, investors, and executives for Destiny Pharma. Use the PitchBook Platform to explore the full profile.See details»
Destiny Pharma Plc Company Profile - Overview - GlobalData
Destiny Pharma Plc (Destiny Pharma) is a drug development and discovery company. It offers commercial exploitation and clinical development of antibacterial products. The company …See details»
Clinical development update - Destiny Pharma
Jan 31, 2024 Destiny Pharma plc (“Destiny Pharma” or “the Company”) Clinical development update Positive Results from XF-73 Dermal Safety Study XF-73 Dermal to be progressed …See details»
Destiny Pharma Plc Locations - Headquarters & Offices - GlobalData
View Destiny Pharma Plc company headquarters address along with its other key offices and locations.See details»
Destiny Pharma plc | Insights
Jul 15, 2024 Destiny Pharma plc is set to become the latest UK biotech to bid farewell to the London Stock Exchange’s Alternative Investment Market (AIM) and will take the private route …See details»
Reports And Presentations - Destiny Pharma
Jul 15, 2024 Financial reports 2023 Report and Financial Statements 2023 Full Year Results announcement 2023 Interim Results 2022 Report and Financial Statements 2022 Full Year ...See details»
Simplification for success: Rewiring the biopharma operating model
5 days ago Less than a third of the 50 leaders we surveyed believe their organization currently possesses the talent and capabilities required to support future product portfolios, including …See details»
Destiny Pharma | Strategy/Company/Ops Update - Destiny Pharma
Jan 17, 2022 Destiny Pharma plc (“Destiny Pharma” or “the Company”) Trading update and outlook for 2022 Brighton, United Kingdom, 17 January 2022 – Destiny Pharma plc (AIM: …See details»